Trust in the U.S. Food and Drug Administration (FDA) declined after its approval of the controversial Alzheimer’s drug aducanumab. Three experts resigned amid allegations that the FDA had caved to industry pressure. Some argue that its credibility has reached a new low. These events should have prompted the FDA to pause, reflect, and work to repair its reputation. Instead, the

The post The FDA’s Proposed Kratom Ban is a Mistake appeared first on Harris Bricken.

On August 19, 2021, New Jersey’s Cannabis Regulatory Commission (CRC) released its “Initial Rules for Personal-Use of Cannabis” (Initial Rules). Th Initial Rules were much anticipated, more so given New Jersey’s proximity to New York and the potential impact these rules could have on New York’s pending program. The Initial Rules cover all aspects of

The post New Jersey Cannabis: Initial Rules for Adult Use Program – Part 1 appeared first on Harris Bricken.